CII
EW icon

Capital International Inc’s Edwards Lifesciences EW Stock Holding History

Capital International Inc’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-24,389
Closed -$1.61M – 309
2024
Q3 		$1.61M Sell
24,389
-13,817
-36% -$1M 0.02% 267
2024
Q2 		$3.53M Sell
38,206
-43,146
-53% -$3.82M 0.05% 223
2024
Q1 		$7.77M Sell
81,352
-49,943
-38% -$4.2M 0.11% 177
2023
Q4 		$10M Sell
131,295
-275,689
-68% -$19.2M 0.16% 154
2023
Q3 		$28.2M Buy
406,984
+25,046
+7% +$2.01M 0.54% 55
2023
Q2 		$36M Buy
381,938
+38,596
+11% +$3.35M 0.65% 43
2023
Q1 		$28.4M Buy
343,342
+46,839
+16% +$3.68M 0.57% 51
2022
Q4 		$22.1M Buy
296,503
+12,509
+4% +$964K 0.48% 65
2022
Q3 		$23.5M Sell
283,994
-270,859
-49% -$26.1M 0.52% 60
2022
Q2 		$52.8M Sell
554,853
-5,280
-0.9% -$547K 0.73% 41
2022
Q1 		$65.9M Sell
560,133
-43,374
-7% -$4.87M 0.74% 43
2021
Q4 		$78.2M Sell
603,507
-1,412
-0.2% -$165K 0.73% 43
2021
Q3 		$68.5M Sell
604,919
-75,768
-11% -$8.65M 0.66% 54
2021
Q2 		$70.5M Sell
680,687
-26,998
-4% -$2.54M 0.63% 54
2021
Q1 		$59.2M Sell
707,685
-54,920
-7% -$4.64M 0.55% 61
2020
Q4 		$69.6M Buy
762,605
+4,596
+0.6% +$381K 0.65% 49
2020
Q3 		$60.5M Buy
758,009
+1,197
+0.2% +$93.4K 0.67% 51
2020
Q2 		$52.3M Buy
756,812
+42,353
+6% +$3.01M 0.64% 54
2020
Q1 		$44.9M Buy
714,459
+49,185
+7% +$3.55M 0.76% 52
2019
Q4 		$51.7M Buy
665,274
+29,622
+5% +$2.31M 0.72% 54
2019
Q3 		$46.6M Buy
635,652
+593,760
+1,417% +$41.7M 0.7% 62
2019
Q2 		$2.58M Buy
+41,892
New +$2.53M 0.18% 112

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Capital International Inc's EW Position: Q4 2024 in Review

Capital International Inc sold out of Edwards Lifesciences (EW) in Q4 2024, closing a stake of 24,389 shares — an estimated $1.61M sold.

Capital International Inc first reported a position in EW in Q2 2019 and held it in 22 quarters. The position peaked at $78.2M in Q4 2021. 1,228 funds tracked by Wall St. Rank hold EW as of Q4 2024.

  • Capital International Inc reported no remaining Edwards Lifesciences position as of Q4 2024 after selling out during the quarter.
  • Capital International Inc sold 24,389 Edwards Lifesciences shares in Q4 2024, an estimated $1.61M.
  • Capital International Inc first reported a position in Edwards Lifesciences in Q2 2019 and held it in 22 quarters.
  • Capital International Inc's Edwards Lifesciences position peaked at $78.2M in Q4 2021.
  • 1,228 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2024.

Based on Capital International Inc's 13F filing for Q4 2024, filed 13 Feb 2025.